Association of mutation and expression of the brother of the regulator of imprinted sites (BORIS) gene with breast cancer progression-Reference-Cited by-同舟云学术

Association of mutation and expression of the brother of the regulator of imprinted sites (BORIS) gene with breast cancer progression

Published:2023-05-26 Issue:1 Volume:14 Page:528-541
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Akhtar Mohammad Salman¹²,Akhter Naseem²³,Talat Arshi⁴,Alharbi Raed A.⁵,Sindi Abdulmajeed A.A.¹,Klufah Faisal⁵,Alyahyawi Hanan E.⁵,Alruwetei Abdulmohsen⁶,Ahmad Abrar⁷,Zamzami Mazin A.⁷,Deo SVS⁸,Husain Syed Akhtar²,Badi Osama A.⁷,Khan Mohammad Jahir⁹

Affiliation:

1. Department of Basic Medical Sciences, Faculty of Applied Medical Sciences, Al-Baha University, Al-Baha, Saudi Arabia

2. Department of Biosciences, Faculty of Natural Sciences, Jamia Millia Islamia, New Delhi, India

3. Department of Neurology, Henry Ford Health System, Detroit, MI 48202, USA

4. Department of Orthodontics and Dentofacial Orthopedics, ITS Dental College, Hospital and Research Centre, Greater Noida, Delhi-NCR, India

5. Department of Laboratory Medicine, Faculty of Applied Medical Sciences, Al-Baha University, Al-Baha, Saudi Arabia

6. Department of Medical Laboratory, College of Applied Medical Sciences, Qassim University, Qassim, Saudi Arabia

7. Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia

8. Department of Surgical Oncology, BRA- IRCH, All India Institute of Medical Sciences (AIIMS), New Delhi, India

9. School of Biotechnology, Jawahar Lal Nehru University, New Delhi, India

Publisher

Impact Journals, LLC

Subject

Oncology

Reference78 articles.

1. Breast Cancer: A Molecularly Heterogenous Disease Needing Subtype-Specific Treatments;Pelosi;Med Sci (Basel),2020

2. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Bray;Int J Cancer,2015

3. Crosstalk of Cyclin-dependent kinase inhibitor 1A (CDKN1A) gene polymorphism with p53 and CCND1 polymorphism in breast cancer;Ahmad;Eur Rev Med Pharmacol Sci,2021

4. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Jemal;CA Cancer J Clin,2018

5. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods;Bray;Int J Cancer,2019